FDA approves COVID antiviral pill as scientists learn more about risk from Omicron

FAN Editor

FDA approves COVID antiviral pill as scientists learn more about risk from Omicron – CBS News

Watch CBSN Live


New studies out of South Africa and the U.K. suggest the Omicron variant is less likely to cause hospitalizations — but it can still be deadly. The FDA also authorized a new antiviral pill to treat COVID-19. CBS News’ Nancy Chen reports on the latest, and then Dr. Amesh Adalja, an infectious disease expert at Johns Hopkins University Bloomberg School of Public Health, spoke with Jessi Mitchell on CBSN about the Omicron research and how some patients are experiencing different symptoms than earlier strains.

View CBS News In

Be the first to know

Get browser notifications for breaking news, live events, and exclusive reporting.

Free America Network Articles

Leave a Reply

Next Post

Jurors in the Elizabeth Holmes trial may take next week off

The jurors assessing 11 charges of fraud and conspiracy against former Theranos CEO Elizabeth Holmes began their third day of deliberations Thursday By MICHAEL LIEDTKE AP Technology Writer December 23, 2021, 6:17 PM • 3 min read Share to FacebookShare to TwitterEmail this article SAN JOSE, Calif. — The jurors […]

You May Like